Olga Ophorst

Replication-Deficient Human Adenovirus Type 35 Vectors for Gene Transfer and Vaccination: Efficient Human Cell Infection and Bypass of Preexisting Adenovirus Immunity

Ronald Vogels, David Zuijdgeest, Richard van Rijnsoever et al. · Journal of Virology · 2003 · 467 citations · Full text

Vaccination, Human Ad35, Gene Therapies +14

Exploiting the Natural Diversity in Adenovirus Tropism for Therapy and Prevention of Disease

Menzo Havenga, Angelique A. C. Lemckert, Olga Ophorst et al. · Journal of Virology · 2002 · 191 citations · Full text

An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity

Olga Ophorst, Stefan Kostense, Jaap Goudsmit et al. · Vaccine · 2004 · 78 citations

Vaccination, Type 35, Vaccine Development +7

Immunogenicity and Protection of a Recombinant Human Adenovirus Serotype 35-Based Malaria Vaccine against<i>Plasmodium yoelii</i>in Mice

Olga Ophorst, Kristina Radošević, Menzo Havenga et al. · Infection and Immunity · 2005 · 73 citations · Full text

Vaccination, Vaccine Development, Vaccine Target +15

Skin delivery of trivalent Sabin inactivated poliovirus vaccine using dissolvable microneedle patches induces neutralizing antibodies

Agnese Donadei, Heleen Kraan, Olga Ophorst et al. · Journal of Controlled Release · 2019 · 51 citations

Vaccination, Vaccine Development, Immunology +8